TLSI Q3 2022 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

TLSITriSalus Life Sciences, Inc.

$175M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4M

Gross Profit

$3M82.1% margin

Operating Income

-$8M-206.8% margin

Net Income

-$8M-206.3% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+36.3%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$24M

Total Liabilities

$14M

Stockholders' Equity

$10M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$0	—
Gross Profit	$3M	$0	—
Operating Income	-$8M	-$807,259	-904.8%
Net Income	-$8M	$2M	-534.0%